Adicet Bio, INC Schedule 13D activist filings

OrbiMed Advisors and affiliated entities have reduced their beneficial ownership in Adicet Bio, Inc. by over 1%, reporting a combined stake of 8.8% as of April 10, 2026.

OrbiMed entities updated their beneficial ownership in Adicet Bio, Inc. following a registered direct offering that increased the issuer's outstanding shares.